image credit- shutterstock
Soukya International Holistic Health Centre, globally acclaimed for its premium holistic therapies, has acquired six acres of land near its existing campus in Hoskote, Bengaluru, as part of its plans to establish a 100-bedded AYUSH hospital focused on making integrative healthcare more accessible.
The total project cost is estimated at Rs 125 crore, which includes Rs 50 crore for land acquisition and Rs 75 crore towards construction and development. The upcoming facility will offer integrated care for a wide spectrum of serious, chronic, rare, and complex medical conditions, combining Allopathy, Ayurveda, Homeopathy, Naturopathy, Siddha, Unani, and Yoga with complementary therapies.
Renowned for setting global benchmarks in holistic wellness, Soukya has pioneered a distinctive model that seamlessly blends medical science with traditional healing, natural remedies, and preventive care. This expansion marks a pivotal milestone in its journey, extending integrative wellness to a broader community at a time when India’s AYUSH ecosystem is witnessing unprecedented growth and policy support.
The Ministry of AYUSH’s FY26 allocation has risen by 14.2% to Rs 3,992.9 crore ($ 461.3 million), while the Indian AYUSH market, valued at $ 43.3 billion in 2024, is projected to reach $ 200 billion by 2030. In parallel, India’s wellness tourism sector, expected to grow from Rs 1.64 lakh crore to Rs 2.57 lakh crore by 2031, reflecting the global surge in demand for Ayurveda, yoga, and holistic rejuvenation.
Construction of the new hospital is expected to begin within the next 6-9 months and will be executed in two phases. Phase I will include 50 beds and a set of core specialisations, while Phase II will expand the facility’s capacity and service portfolio. The hospital is expected to be fully functional by the end of FY 27.
The 100 bedded hospital in Bengaluru will provide advanced integrative care across multiple disciplines, including cancer rehabilitation, respiratory disorders, lifestyle and metabolic conditions, pediatric developmental disorders, reproductive health, neurological and musculoskeletal disorders, gastrointestinal diseases, and addictive behaviours.